Expanding the use and interpretation of patient-centric cardiovascular clinical trial endpoints
Significant improvements have been achieved to enhance the patient-centricity of clinical research, including the development and utilization of novel clinical trial endpoints. These include endpoints that harness outcomes that are important to patients and reflect the patients’ lived experiences. T...
Saved in:
| Main Authors: | Shelby D. Reed, Pishoy Gouda |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Cambridge University Press
2025-01-01
|
| Series: | Journal of Clinical and Translational Science |
| Subjects: | |
| Online Access: | https://www.cambridge.org/core/product/identifier/S205986612510054X/type/journal_article |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Sarcopenia in Ageing and Chronic Illness: Trial Endpoints and Regulatory Issues
by: Stephan vonHaehling, et al.
Published: (2025-06-01) -
Time to deterioration of patient-reported outcome endpoints in cancer clinical trials: targeted literature review and best practice recommendations
by: Kim Cocks, et al.
Published: (2024-12-01) -
Preserving Trial Endpoint Specificity and Cause of Death Attribution in Cardiovascular Trials
by: Shea E. Hogan, MD, MSCS, et al.
Published: (2025-06-01) -
A patient-centric benefit-risk assessment of daridorexant for the treatment of insomnia disorder using patient preference data collected in two phase 3 clinical trials
by: Sebastian Heidenreich, et al.
Published: (2025-12-01) -
Drug development for rare diseases: a case for patient-centricity, equity, and access to clinical trials
by: Allison E. Bowen, et al.
Published: (2025-05-01)